T. Rowe Price Associates’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $63K | Buy |
|
|||||
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $65K | Buy |
|
|||||
|
2025
Q1 | $48K | Sell |
|
|||||
|
2024
Q4 | $86K | Buy |
|
|||||
|
2024
Q3 | $1.04M | Buy |
|
|||||
|
2024
Q2 | $430K | Buy |
|
|||||
|
2024
Q1 | $636K | Buy |
|
|||||
|
2023
Q4 | $673K | Buy |
|
|||||
|
2023
Q3 | $460K | Buy |
|
|||||
|
2023
Q2 | $656K | Sell |
|
|||||
|
2023
Q1 | $651K | Buy |
|
|||||
|
2022
Q4 | $750K | Sell |
|
|||||
|
2022
Q3 | $1.16M | Buy |
|
|||||
|
2022
Q2 | $755K | Sell |
|
|||||
|
2022
Q1 | $1.05M | Buy |
|
|||||
|
2021
Q4 | $1M | Buy |
|
|||||
|
2021
Q3 | $1.32M | Sell |
|
|||||
|
2021
Q2 | $1.87M | Sell |
|
|||||
|
2021
Q1 | $1.6M | Buy |
|
|||||
|
2020
Q4 | $92K | Buy |
|